About Alan J. Morrison

 

Alan J. Morrison founded the Law Offices of Alan J. Morrison in 2014.  Prior to that, he was a partner at the New York firms of Cozen O’Connor, Cohen, Pontani, Lieberman & Pavane LLP and Cooper & Dunham LLP.  He also served as in-house counsel at Johnson & Johnson in New Brunswick, New Jersey.

Mr. Morrison counsels his clients in the biotechnology and pharmaceutical fields regarding patents and related transactional law.  In that regard, he has considerable experience rendering opinions on patent infringement and invalidity, as well as patentability, inventorship, inequitable conduct, and the Hatch-Waxman Act.  His experience also encompasses evaluating patent portfolios, and preparing and negotiating pharmaceutical and biotech contracts.  These contracts include patent licenses, joint development agreements, research collaboration agreements, feasibility study agreements and technology transfer agreements.

Since his practice began, Mr. Morrison has engaged in all aspects of U.S. and international patent prosecution in the biotech and pharmaceutical fields.  He has represented corporations, universities and research institutes in protecting groundbreaking inventions such as recombinant antibody drugs, catalytic nucleic acids, DNA microarrays, diagnostic methods and kits, pharmaceutical formulations, stem cell-based methods, and small molecule drug synthesis.

In his more than 20 years of practice, Mr. Morrison has represented some of the world’s largest, most prestigious and most innovative companies and institutions, and was selected as a Super Lawyer by Super Lawyers® of Thomson Reuters.  He has counseled CEO’s, venture capitalists and Nobel laureates, and has aided his clients in matters exceeding a billion dollars in value.

Mr. Morrison also holds an adjunct faculty position in the Department of Biological Sciences at Columbia University, where he teaches a graduate course called “Biotechnology Law.”  The course, which he designed, is the first of its kind at Columbia.  He also teaches a related graduate course called “Ethics in Biopharmaceutical Patent and Regulatory Law”, which he designed, and which is the first of its kind at Columbia.

In addition to teaching at Columbia, Mr. Morrison has lectured extensively in the United States, Europe, Asia and Africa on various topics in patent and regulatory law, and has written and spoken on controversial topics such as gene patenting and biosimilars law.  He is co-chair emeritus and a founding member of the advisory board for the Bellevue/NYU Program for Survivors of Torture.  He has also served on the advisory boards of the Stem Cell Partnering Series and the Columbia University Biotechnology Association.  Before studying law, he studied Chinese at the Beijing Language Institute in China.

Mr. Morrison earned a B.A. in biochemistry from the University of California, Berkeley, in 1984; an M.S. in biological chemistry from the University of Michigan in 1986; an M.Phil. in biochemistry and molecular biophysics from Columbia University in 1988; and a J.D. from the Benjamin N. Cardozo School of Law, Yeshiva University in 1992.

 

Selected Papers and Presentations

Lowering drug prices by shorting drug companies' stocks while attacking their patents - public service or ethical breach?presented as part of the Global Bioethics course, New York University, New York, New York, May 2, 2017 (Sole Lecturer).

Short selling a drug company's stock in conjunction with challenging its drug patents through inter partes reviewpresented as part of the Ethics for Biomedical Engineering course, Columbia University, New York, New York, April 19, 2017 (Sole Lecturer).

The Biotechnology Patent: Today's Challenges, presented at Fundamentals of the Bioscience Industry, Center for Biotechnology, New York, New York, February 2, 2017 (Sole Lecturer).  

After AMP v. Myriad - Using trade secret protection for genetic testing innovations, presented at Weill Cornell Medical College and hosted by the Weill Cornell Biotech Club, New York, New York, November 7, 2016 (Sole Lecturer). 

Patent Inventorship in the United States, and Why It Matters, Third Annual Conference of the Sino-American Pharmaceutical Professionals Association - Connecticut, co-organized by the Association of Chinese Students and Scholars at Yale and the Chinese Association for Science and Technology, New Haven, Connecticut, October 8, 2016 (Lecturer).

Patent Inventorship and Infringement, presented in two parts as part of the intellectual property course at the Icahn School of Medicine at Mount Sinai, New York, New York, September 13 and 20, 2016 (Sole Lecturer). 

The ethics of maintaining a patient's genetic information as a trade secret: the case of Myriad Genetics' human BRCA VUS database, presented as part of the Ethics for Biomedical Engineering course, Columbia University, New York, New York, April 27, 2016 (Sole Lecturer).

Biotechnology Patents and the Latest Drama, presented at Fundamentals of the Bioscience Industry, Center for Biotechnology, New York, New York, February 9, 2016 (Sole Lecturer).

Hey!  That's my invention!  Why inventorship matters in U.S. patent law, and what happens when we get it wrong, presented at Weill Cornell Medical College and hosted by the Weill Cornell Biotech Club, New York, New York, September 24, 2015 (Sole Lecturer).

The Supreme Court’s Myriad and Prometheus Decisions, and Their Effect on Healthcare, presented as part of the Ethics for Biomedical Engineering course, Columbia University, New York, New York, April 29, 2015 (Sole Lecturer).

Filing Your First Biotech Patent Application: Strategies for Startups – Part 2, presented at Harlem Biospace, New York, New York, February 23, 2015 (Sole Lecturer). 

Biotechnology, Patents and the FDA, presented at Fundamentals of the Bioscience Industry, Center for Biotechnology, New York, New York, January 29, 2015 (Sole Lecturer).

Filing Your First Biotech Patent Application: Strategies for Startups – Part 1, presented at Harlem Biospace, New York, New York, November 17, 2014 (Sole Lecturer).

The U.S. Supreme Court’s AMP v. Myriad Decision, and its Ethical Implications, presented as part of the Ethics for Biomedical Engineering course, Columbia University, New York, New York, April 25, 2014 (Sole Lecturer).

Protecting Biotechnology in an Era of Judicial Hostility, presented at Fundamentals of the Bioscience Industry, Center for Biotechnology, New York, New York, January 30, 2014 (Sole Lecturer).

Alan J. Morrison and Richard T. Ruzich, Gunn v. Minton and the Patent Malpractice Case, Intellectual Property Magazine, October 2013, 62-63.

Alan J. Morrison, Supreme Court's Myriad Decision on Patenting Isolated DNA, Cozen O'Connor Intellectual Property Alert, June 17, 2013

The Ethics of Reverse Payment Agreements between Brand Name and Generic Drug Companies under the Hatch-Waxman Act and The U.S. Supreme Court and the Future of Human Gene Patents, presented as part of the Ethics for Biomedical Engineering course, Columbia University, New York, New York, April 24, 2013 (Sole Lecturer).

Alan J. Morrison, Protecting Your Patents by Getting Inventorship Right, Cozen O’Connor Business Law Observer, Winter 2013.  

Protecting Biotechnology Inventions, presented at Fundamentals of the Bioscience Industry, Center for Biotechnology, New York, New York, January 31, 2013 (Sole Lecturer).

The U.S. Patent: An Update, presented at the Beijing Foreign Studies University Law School, Beijing, China, April 9, 2012 (Sole Lecturer).

Biotechnology Patent Protection in the United States, presented at the Seminar on Special Topics in Exploring Anhui Province’s Corporate Investment and Development Opportunities in the United States, held under the auspices of the Anhui Provincial Government’s Development Research Center, Hefei City, Anhui Province, China, April 7, 2012 (Lecturer).

The Bioethics of DNA Patents and Pay-for-Delay Schemes, presented as part of the Ethics for Biomedical Engineering course, Columbia University, New York, New York, February 8, 2012 (Sole Lecturer).

Intellectual Property Law for Biotechnology, presented at Fundamentals of the Bioscience Industry, Center for Biotechnology, New York, New York, February 2, 2012 (Sole Lecturer).

The New Waiting Game: Biosimilar Drugs and the 12-Year Exclusivity Period, presented as part of the Symposium on Access to Essential Medicines, Biotechnology Patents, and Global Cooperation, Temple University, Beasley School of Law, Philadelphia, Pennsylvania, April 1, 2011 (Lecturer).

The Bioethics of Gene Patents, presented as part of the Ethics for Biomedical Engineering course, Columbia University, New York, New York, February 16, 2011 (Sole Lecturer).

Special Topics in Biotechnology Law, presented at Fundamentals of the Bioscience Industry, Center for Biotechnology, New York, New York, February 8, 2011 (Sole Lecturer).

Introduction to Intellectual Property for the Biosciences, presented at Fundamentals of the Bioscience Industry, Center for Biotechnology, New York, New York, February 3, 2011 (Sole Lecturer).

Alan J. Morrison, Rethinking the Gene Patent, Biotechnology Law Report. December 2010, 29(6): 609-614.

Podcast interview of Alan J. Morrison by Doris Gilman of Health Thought Leadership One-to-One, November 1, 2010, providing an introduction to the topic of gene patents.

Should Genes Be Patented?, a panel discussion with Dr. Wendy Chung, Alan J. Morrison, Esq. and Dr. John Loike, presented at Columbia University and hosted by Columbia Technology Ventures, New York, New York, April 28, 2010 (Panelist).

Challenging the Biotech Patent: The ACLU Takes on Myriad Genetics and the U.S. Patent Office, presented at Fundamentals of the Bioscience Industry, Center for Biotechnology, New York, New York, February 9, 2010 (Lecturer).

IP Issues in the Therapeutic Antibody Industry (Chapter 39 of Antibody Engineering), United States subchapter of Patent Enforcement (39.4.13), Springer-Verlag Berlin Heidelberg, 2010 (Contributor).

What Price Biosimilars? Balancing the Innovation and Cost of Biologics in America, presented at Biologic India 2009, Mumbai, India, December 2, 2009 (Lecturer).

Understanding the U.S. Biotechnology Patent, presented at Sun Yat-Sen University, Guangzhou, China, June 16, 2009 (Sole Lecturer).

Selected Developments in U.S. Biotech Patent Law - 2009, presented at the Workshop on Biotechnology Patent Law, hosted by Michalski Hüttermann and Partner, Düsseldorf, Germany, May 5, 2009 (Lecturer). 

Understanding the Biotechnology Patent, presented to the Master’s Program in Biotechnology, Columbia University, New York, New York, March 11, 2009 (Sole Lecturer).

Ethical Issues Concerning Human Embryonic Stem Cell Patents, presented at the second annual meeting of The Stem Cell Partnering Series, held at the University of California, San Diego, La Jolla, California, February 27, 2009 (Lecturer and Meeting Co-Chair).

Selected Thoughts on Legal Writing in Patent Law, presented to The Scientific Patent Law Group in New York and The New York Academy of Sciences, held at The New York Academy of Sciences, New York, New York, February 19, 2009 (Sole Lecturer).

Alan J. Morrison, Patenting DNA in the United States, Managing Intellectual Property (December 2008/January 2009).

Legal Hurdles and Strategies in Building a University Biotech Portfolio, presented as part of the panel on Building a Strong University Biotech Patent Portfolio, held at the 2008 Life Sciences Industry Summit, Long Island, New York, June 5, 2008 (Panel Chair and Lecturer). 

Selected Topics in U.S. Biotech Patent Law, presented at the Workshop on Biotechnology Patent Law, hosted by Michalski Hüttermann and Partner, Düsseldorf, Germany, May 16, 2008 (Lecturer).

Panel on Patenting Stem Cells at the Inaugural Conference on Fostering Business Collaboration & Careers in Stem Cell Science, hosted by the Stem Cell Partnering Series at U.C. San Diego, La Jolla, California, February 29, 2008 (Moderator). 

Biosimilars in the United States: An Update, presented at Biosimilars 2007 organized by Visiongain, London, United Kingdom, December 6, 2007 (Speaker).

Alan J. Morrison, Biosimilars in the United States: A Brief Look at Where We Are and the Road Ahead, Biotechnology Law Report. October 2007, 26(5): 463-468.

Understanding, Prosecuting and Enforcing Biotech and Pharmaceutical Patents in the United States, presented at the 2007 IP Workshop for Biotech Pharmaceutical Industry (Including Generic Drug Entry in the US), held under the auspices of the Center for Drug Evaluation, Taipei, Taiwan, April 2, 2007 (Lecturer).

Trade Secret Protection: When and How It Should Be Used, presented at Effective Corporate IP Programs organized by Law Seminars International, Atlanta, Georgia, December 1, 2005 (Speaker and Co-Author).

Double Patenting, presented at the Eighteenth Annual Pharmaceutical/Chemical Patent Practice Update sponsored by the New Jersey Intellectual Property Law Association, Committee on Chemical Practice, Iselin, New Jersey, December 9, 2004 (Speaker and Co-Author).

U.S. Biotechnology and Pharmaceutical Law, an introductory lecture series presented as part of the Recovering Nations Project, and co-hosted by the Freetown law firm of Roberts & Partners, Freetown, Sierra Leone, November 22-24, 2004 (Co-Developer and Sole Lecturer).

Non-Patent Protection for Biopharmaceuticals, presented at Biopharmaceuticals: Running the Race from Drug Discovery to Commercialization organized by Law Seminars International, Raleigh, North Carolina, May 3, 2004 (Speaker and Co-Author).

Determining Inventorship under United States Patent Law, presented at the Conference on Protection of Intellectual Property Rights sponsored by the Center for International Legal Studies, Kitzbühel, Austria, March 15, 2004 (Speaker and Author). 

Non-Patent Protection for Biotechnology and Pharmaceuticals, presented at Biotechnology from Start to Finish organized by Law Seminars International, San Diego, California, March 8, 2004 (Speaker and Co-Author).

Claim Drafting Workshop: Chemical/Biotechnology, held as part of the American Intellectual Property Law Association's Patent Prosecution Training for New Lawyers, Washington, DC, August 15, 2003 (Workshop Co-Chair).

Determining Inventorship, presented at the Sixteenth Annual Pharmaceutical/Chemical Patent Practice Update sponsored by the New Jersey Intellectual Property Law Association, Committee on Chemical Practice, Iselin, New Jersey, December 12, 2002 (Speaker and Co-Author).

Claim Drafting Workshop: Chemical/Biotechnology, held as part of the American Intellectual Property Law Association’s Patent Prosecution Basic Training, Washington, DC, August 24, 2002, August 17, 2001 and September 21, 2000 (Panelist and Instructor).

Intellectual Property Aspects of Mergers and Acquisitions, presented as part of a course on International Mergers and Acquisitions, New York University, July 31 and November 9, 2000 (Lecturer).

An Overview of Pharmaceutical Patent Practice in the United States, presented at the Symposium on Intellectual Property and the Internationalization of Chinese Medicinal Products, Hong Kong Baptist University, Hong Kong, May 17-19, 1999 (Speaker and Author).

Selected Topics in U.S. Pharmaceutical Patent Practice, hosted by the U.S.-China Intellectual Property Institute, Hong Kong Baptist University, Hong Kong, December 23, 1998 (Lecturer).

Advanced Training Course in U.S. Pharmaceutical Patent Practice, held under the auspices of the Ministry of Technology, Guangzhou, China, September 21-25, 1998 (Lecturer, Co-Author and Co-Developer).